260 results
Page 3 of 13
425
778y2bba77w0gugw8gz
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.1
tsrobl5
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
3it7989ibusvx8
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.1
7hf d5anj1n7118aiavx
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.2
s7z8tl
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
425
66izw4a3ha m8rmqc
27 Apr 22
Business combination disclosure
5:26pm
8-K
EX-99.2
s0xedk5qp2
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
7hr7lu609 6855qe8fs
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-10.2
hbefvgf
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
t2mu0uk1x1qmb090e3zl
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
x80n763jvupun
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
ejzkxn
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.1
lch4i5k0uftqrwydaw7
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
y3q37l0y18hvxeblzrd
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm